Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab have?
Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab published?
Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab has 2021 year in the ScholarIQ index.
What is the open-access status of Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab?
Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab has gold oa status in the ScholarIQ index.
What is the DOI of Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab?
The DOI for Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab is on the source record.
What is the PMID of Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab?
The PMID for Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab is on the source record.
What is the OpenAlex record for Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab?
The OpenAlex for Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab is on the source record.